Lipocalin-2 silencing suppresses inflammation and oxidative stress of acute respiratory distress syndrome by ferroptosis via inhibition of MAPK/ERK pathway in neonatal mice

Neonatal acute respiratory distress syndrome (ARDS) has high morbidity and mortality rates worldwide, but there is a lack of pharmacologic treatment and clinical targeted therapies. In this study, we aimed to explore the effects of Lipocalin-2 (LCN2) on ferroptosis-mediated inflammation and oxidativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaodong, Zhang, Chunhua, Zou, Na, Chen, Qinghua, Wang, Chaojun, Zhou, Xu, Luo, Li, Qi, Haibin, Li, Junhua, Liu, Zhiyan, Yi, Jinghong, Li, Jing, Liu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805876/
https://www.ncbi.nlm.nih.gov/pubmed/34969358
http://dx.doi.org/10.1080/21655979.2021.2009970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805876/
https://www.ncbi.nlm.nih.gov/pubmed/34969358
http://dx.doi.org/10.1080/21655979.2021.2009970

Ejemplares similares